Upstream Bio Stock Forward View - 20 Period Moving Average
| UPB Stock | 9.09 0.10 1.11% |
Upstream Bio's 20 Period Moving Average forecast is generated from the selected price series and evaluated against observed values. Forecast accuracy depends on how stable the recent price trend has been — trending markets suit some models better than others. The 20 Period Moving Average model projects Upstream Bio at 9.47 for the next trading day, above the most recent closing price. All values shown are model-generated projections and should be evaluated alongside other analytical inputs.
20 Period Moving Average Price Forecast For the 11th of May 2026
Over a 90-day horizon, the 20 Period Moving Average model forecasts Upstream Bio at 9.47 for the next trading day, with a mean absolute deviation of 0.59 , mean absolute percentage error of 0.06 , and sum of absolute errors of 24.06 .This indicates moderate forecast accuracy — the model captures the general trend but not all short-term variation in Upstream Bio's price. This output is intended for short-term analytical reference.
Stock Forecast Pattern
| Backtest Upstream Bio | Upstream Bio Price Prediction | Research Analysis |
Forecasted Value
This forecast for Upstream Bio frames the expected trading range using downside and upside bounds rather than a single point target. The projected band runs from roughly 1.10 on the downside to about 17.84 on the upside. The wide range indicates elevated uncertainty in short-term projections.
Model Predictive Factors
The table below summarizes the 20 Period Moving Average model's error metrics for Upstream Bio stock. Lower MAD and MAPE values indicate tighter forecast accuracy. AIC measures relative model quality — lower values indicate less information loss and a better-fitting model. A large Bias suggests systematic over- or under-prediction.| AIC | Akaike Information Criteria | 80.6373 |
| Bias | Arithmetic mean of the errors | -0.285 |
| MAD | Mean absolute deviation | 0.5869 |
| MAPE | Mean absolute percentage error | 0.0612 |
| SAE | Sum of the absolute errors | 24.0645 |
Other Forecasting Options for Upstream Bio
Bollinger Bands applied to Upstream Bio Stock price data measure how far Upstream Bio has deviated from its recent average relative to its own volatility. This distinction drives the choice of forecasting model applied to Upstream Bio's price data.Upstream Bio Related Equities
These firms work in a similar space as Upstream Bio within the Health Care space and serve as useful points for comparison. Looking at Upstream Bio's pricing multiples next to these peers shows if the stock trades at a premium or discount. Persistent outperformance or underperformance by specific peers relative to Upstream Bio often signals structural advantages or weaknesses. Peer review is one of the most widely used methods in stock research and portfolio building.
| Risk & Return | Correlation |
Upstream Bio Market Strength Events
Market strength indicators for Upstream Bio quantify how the stock responds to shifts in volume and sentiment. These indicators capture shifts in momentum that may precede significant price moves in Upstream Bio.
Upstream Bio Risk Indicators
Analyzing Upstream Bio's risk indicators separates symmetric price swings from asymmetric downside exposure. Understanding and quantifying the risks present in Upstream Bio helps place recent price behavior in context.
| Mean Deviation | 4.57 | |||
| Standard Deviation | 8.34 | |||
| Variance | 69.6 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Upstream Bio Short Properties
Reviewing short-oriented indicators for Upstream Bio is useful because long and short participants often create very different signals for timing and volatility. This is applicable when the question is whether bearish pressure is starting to shape the market's reaction function.
| Common Stock Shares Outstanding | 53.85 million | |
| Cash And Short Term Investments | 341.51 million |